Izotropic Corporation | News
6/30/2021
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering

6/3/2021
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units

5/28/2021
Izotropic Provides Corporate Update

4/20/2021
Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board

3/24/2021
Izotropic Accelerates Payor Engagement Activities with Excite International

3/18/2021
Izotropic Launches Marketing Campaign

3/15/2021
Izotropic Appoints Dr. John McGraw as Chief Executive Officer

3/4/2021
Initial Insurance Billing Codes Issued for Dedicated Breast CT in the USA

2/19/2021
Izotropic Launches New Website and Corporate Presentation

2/9/2021
Izotropic Unveils “izoview” Branding For Breast CT Platform In Development And Files Trademark Applications

2/3/2021
Izotropic Announces Upgrade to OTCQB Venture Market

1/11/2021
Izotropic Grants Restricted and Performance Share Units

1/7/2021
3D CT Imaging Expert Joins Izotropic Advisory

1/5/2021
Izotropic Positioned to Execute in 2021

12/31/2020
Izotropic Technology Founder Appointed Editor-In-Chief Of Medical Physics Journal

12/15/2020
Izotropic Reports High Degree of Confidence After Pre-Submission Meeting With FDA

12/9/2020
Izotropic Corporation Announces Closing of Non-Brokered Private Placement

12/1/2020
Izotropic Cancels Options and Updates Amount of Broker Warrant Issued

11/2/2020
Izotropic Engages Investor Relations and Market Awareness Consultants

10/30/2020
Izotropic Corporation Announces Closing of Second Tranche of Non-Brokered Private Placement

10/26/2020
Izotropic Unaware of Any Material Change

10/20/2020
Izotropic Corporation Announces Non-Brokered Private Placement

10/6/2020
Izotropic Announces 2020 AGM Results

9/28/2020
Izotropic Announces Meeting Date With FDA

9/15/2020
Mr. Alexander Tokman Joins Izotropic as Strategic Advisor

8/31/2020
Izotropic Engages Marketsmart Communications

8/28/2020
Izotropic Appoints Jaclyn Thast as Corporate Secretary

8/18/2020
Izotropic Files Pre-Submission Application With U.S. FDA

8/4/2020
Izotropic Unaware of Any Material Change

7/10/2020
Izotropic Corporation Announces Adoption of Long Term Incentive Plan

7/8/2020
Izotropic Engages Dr. Craig Abbey for Breast CT Reader Study Design

7/6/2020
Izotropic Corporation Appoints Executive Vice President of Commercial Operations

6/4/2020
Izotropic Engages Mr. James Berard for Investor Relation Services

6/1/2020
Izotropic Corporation Announces Warrant Amendment

5/27/2020
Izotropic Corporation Announces Issuance of Warrants Pursuant to January Warrant Incentive Program, Delayed Due to Covid-19

5/25/2020
Izotropic Begins FDA Approval Process

5/20/2020
FDA Consultant Joins Izotropic Advisory Board

5/13/2020
Izotropic Engages Starfish Medical for Design and Development of Commercial Breast CT Model

5/7/2020
Izotropic Announces Issuance of Patent to Use Breast CT for Robotic Guided Biopsy

4/22/2020
Izotropic Announces Addition of George Burkett, M.Eng to Advisory Board

4/15/2020
Izotropic Announces Issuance of Patent to Measure Breast Density With Breast CT Technology

2/27/2020
Izotropic Provides Update on Globally Licensed Breast CT Technology

2/26/2020
Izotropic Successfully Extends Exclusive Global License Agreement for Innovative Breast CT Technology Until 2027

2/19/2020
Izotropic Receives Notice of Allowance for Measuring Breast Density From US Patent Office

2/13/2020
Izotropic Corporation Announces Apppointment of Dr. John Mcgraw to Advisory Board

2/11/2020
Izotropic Corporation Raises $1.23M From Warrant Exercise Program

2/5/2020
Izotropic Corporation Receives Notice of Allowance From US Patent Office

1/28/2020
Izotropic Corporation Announces Warrant Exercise Incentive Program

1/23/2020
Izotropic Corporation Announces Cancellation and Issuance of Stock Options

1/8/2020
What Could Google’s AI Capability Do with Real 3D Breast CT Images?